Optimization of Sequences to Improve the Quality and Comfort of the Magnetic Resonance Imaging Examination
Condition(s) studied
Investigational drug(s) / intervention(s)
mri: The people included will carry out an MRI comprising the sequence currently used in routine care and the different variants of the sequence being tested, for the optimization of the parameters. The duration of the examination (or the extension of the examination planned as part of patient care) will be from a few minutes to an hour depending on the sequences to be optimized. Subjects who agree to research for more than 30 minutes in the MRI machine will be compensated with a multi-brand gift voucher worth 30 euros.
Study summary
The people included will carry out an MRI comprising the sequence currently used in routine care and the different variants of the sequence being tested, for the optimization of the parameters. The duration of the examination (or the extension of the examination planned as part of patient care) will be from a few minutes to an hour depending on the sequences to be optimized. Subjects who agree to research for more than 30 minutes in the MRI machine will be compensated with a multi-brand gift voucher worth 30 euros.
Eligibility
Primary outcome measure(s)
- Quality of imagery — Baseline
Quality of imagery evaluated on a likert-type scale (range from : "very bad quality" to "very good quality") by two experts - Presence or absence of radiological image artifact — Baseline
Presence/absence of radiological image artifact evaluated on a likert-type scale (range from : "major - impossible interpretation" to "none") by two experts - Confidence in diagnosis — Baseline
Confidence in diagnosis evaluated on a likert-type scale (range from : "not confident" to "very confident") by two experts
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Fondation Adolphe de Rothschild | Paris | Paris | Recruiting |
More Fondation Ophtalmologique Adolphe de Rothschild trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05326581 on ClinicalTrials.gov ↗ ← All trials in France